Teacher Retirement System of Texas Lowers Holdings in MiMedx Group, Inc (NASDAQ:MDXG)

Teacher Retirement System of Texas decreased its position in MiMedx Group, Inc (NASDAQ:MDXG) by 9.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,641 shares of the company’s stock after selling 3,221 shares during the quarter. Teacher Retirement System of Texas’ holdings in MiMedx Group were worth $240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in MDXG. Virtus Fund Advisers LLC purchased a new position in MiMedx Group during the fourth quarter worth approximately $35,000. Tower Research Capital LLC TRC boosted its position in MiMedx Group by 77.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,501 shares of the company’s stock worth $63,000 after purchasing an additional 2,837 shares in the last quarter. Cibc World Markets Corp purchased a new position in MiMedx Group during the fourth quarter worth approximately $107,000. Ameriprise Financial Inc. purchased a new position in MiMedx Group during the fourth quarter worth approximately $115,000. Finally, Sowell Financial Services LLC purchased a new position in MiMedx Group during the first quarter worth approximately $115,000. Institutional investors own 79.15% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on MDXG shares. Wall Street Zen downgraded MiMedx Group from a “buy” rating to a “hold” rating in a research report on Friday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $11.00 target price on shares of MiMedx Group in a report on Tuesday, July 15th.

Insider Buying and Selling at MiMedx Group

In other news, CEO Joseph H. Capper purchased 200,000 shares of MiMedx Group stock in a transaction dated Friday, May 2nd. The shares were bought at an average cost of $6.34 per share, with a total value of $1,268,000.00. Following the completion of the transaction, the chief executive officer directly owned 529,530 shares in the company, valued at $3,357,220.20. This trade represents a 60.69% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.70% of the company’s stock.

MiMedx Group Price Performance

Shares of NASDAQ:MDXG opened at $6.42 on Friday. MiMedx Group, Inc has a one year low of $5.47 and a one year high of $10.14. The company has a debt-to-equity ratio of 0.09, a quick ratio of 4.13 and a current ratio of 4.70. The company has a market capitalization of $948.25 million, a PE ratio of 23.78 and a beta of 1.76. The stock has a fifty day moving average of $6.48 and a 200-day moving average of $7.40.

MiMedx Group (NASDAQ:MDXG) last released its quarterly earnings results on Wednesday, April 30th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. The company had revenue of $88.21 million during the quarter, compared to analysts’ expectations of $86.32 million. MiMedx Group had a net margin of 11.40% and a return on equity of 22.70%. As a group, equities analysts anticipate that MiMedx Group, Inc will post 0.3 EPS for the current fiscal year.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.